Lyophilization, or freeze-drying, is essential in biopharmaceutical production but presents significant challenges, such as long timelines, high prices, and ...
As biologics programs progress toward commercialization, late-stage development introduces distinct challenges—from scaling processes efficiently to ensuring regulatory readiness and maintaining cost ...
Globally Harmonized Regulatory Approach Is Needed to Move Forward Expeditiously The concept of well-characterized biologicals originated with the FDA Center for Biologics Evaluation and Research (CBER ...